EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Brown Adipose Tissue in Metabolic Health and Efficacy of Drug Treatment for Obesity

Natalia O Markina, Georgy A Matveev iD, German G Zasypkin, Tatiana I Golikova, Daria V Ryzhkova, Yulia A Kononova, Sergey D Danilov iD, Alina Yu Babenko iD

Journal of Clinical Medicine · 16.07.2024 · 13 (14) · 4151

DOI: 10.3390/jcm13144151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.07.2024. Verfasst von Natalia O Markina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Prediabetes and Metabolic Disorders, WCRC "Centre for Personalized Medicine", Almazov National Medical Research Centre, Saint Petersbur…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The grant of the Ministry of Education and Science of the Russian Federation; "Promomed" LLC, Ministry of Education and Science of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Brown adipose tissue (BAT) is responsible for non-shivering thermogenesis, and its activation has become a new object as both a determinant of metabolic health and a target for therapy. This study aimed to identify the relationships between the presence of BAT, parameters that characterize metabolic health (glucose, lipids, blood pressure (BP)), and the dynamics of body mass index (BMI) during weight-reducing therapy. (2)

Methods

The study included 72 patients with obesity. We investigated metabolic parameters, anthropometric parameters, and BP. Dual-energy X-ray absorptiometry (DXA) and positron emission tomography and computed tomography (PET/CT) imaging with 18F-fluorodeoxyglucose (18F-FDG) were performed. (3)

Results

Before weight-reducing therapy, BAT was revealed only in 19% patients with obesity. The presence of BAT was associated with a lower risk of metabolic deviations that characterize metabolic syndrome: shorter waist circumference (WC) (p = 0.02) and lower levels of glucose (p = 0.03) and triglycerides (p = 0.03). Thereafter, patients were divided into four groups according to the type of therapy (only lifestyle modification or with Liraglutide or Reduxin or Reduxin Forte). We did not find a relationship between the presence of BAT and response to therapy: percent weight reduction was 10.4% in patients with BAT and 8.5% in patients without BAT (p = 0.78) during six months of therapy. But we noted a significant positive correlation between the volume of BAT and the effectiveness of weight loss at 3 months (r = 0.52, p = 0.016). The dynamic analysis of BAT after 6 months of therapy showed a significant increase in the volume of cold-induced metabolically active BAT, as determined by PET/CT with 18F-FDG in the Liraglutide group (p = 0.04) and an increase in the activity of BAT standardized uptake value (SUV mean and SUV max) in the Reduxin (p = 0.02; p = 0.01, respectively) and Liraglutide groups (p = 0.02 in both settings). (4)

Conclusions

The presence of brown adipose tissue is associated with a lower risk of metabolic abnormalities. In general, our study demonstrated that well-established drugs in the treatment of obesity (Liraglutide and Reduxin) have one more mechanism for implementing their effects. These drugs have the ability to increase the activity of BAT. A significant positive relationship between the total volume of BAT and the percentage of weight loss may further determine the priority mechanism of the weight-reducing effect of these medicaments.

Schlagwörter

Stichwörter der Autor:innen

brown adipose tissuemetabolic syndromeobesitypositron emission tomography/computed tomographyweight-reducing therapy

Autor:innen und Institutionen

  • Laboratory of Prediabetes and Metabolic Disorders, WCRC "Centre for Personalized Medicine", Almazov National Medical Research Centre, Saint Petersburg 197341, Russia.
  • Facility of Digital Transformation, ITMO University, Saint Petersburg 197101, Russia.

ORCID-Profile: Georgy A Matveev, Sergey D Danilov, Alina Yu Babenko

Förderung

  • The grant of the Ministry of Education and Science of the Russian Federation; "Promomed" LLC
  • Ministry of Education and Science of the Russian Federation

Zitieren

APA

Markina, N. O., Matveev, G. A., Zasypkin, G. G., Golikova, T. I., Ryzhkova, D. V., Kononova, Y. A., Danilov, S. D., & Babenko, A. Y. (2024). Role of Brown Adipose Tissue in Metabolic Health and Efficacy of Drug Treatment for Obesity. Journal of Clinical Medicine, 13(14), 4151. https://doi.org/10.3390/jcm13144151

Vancouver

Markina NO, Matveev GA, Zasypkin GG, Golikova TI, Ryzhkova DV, Kononova YA, et al. Role of Brown Adipose Tissue in Metabolic Health and Efficacy of Drug Treatment for Obesity. Journal of Clinical Medicine. 2024;13(14):4151. doi:10.3390/jcm13144151

BibTeX
@article{Markina2024,
  author = {Markina, Natalia O and Matveev, Georgy A and Zasypkin, German G and Golikova, Tatiana I and Ryzhkova, Daria V and Kononova, Yulia A and Danilov, Sergey D and Babenko, Alina Yu},
  title = {Role of Brown Adipose Tissue in Metabolic Health and Efficacy of Drug Treatment for Obesity},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4151},
  doi = {10.3390/jcm13144151}
}
Kostenlos starten →